MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2018.1480746

Медицинская библиотека · The Journal of dermatological treatment · 2019

Efficacy and survival of biologic agents in psoriasis: a practical real-life 12-year experience in a French dermatology department.

Roche Hélène, Bouiller Kevin, Puzenat Eve, Deveza Elise, Roche Blandine, Pelletier Fabien, van de Laak Alison, Dupond Anne Sophie, Nardin Charlée, Aubin François

СтатьяПеревод пока не подготовлен

Аннотация

Background

Drug survival in a real-life setting is critical to long-term use of biologics for psoriasis.

Objective

We describe our 12-year experience with biologics in psoriasis patients. Patients and

Methods

All patients treated with biologics including infliximab, adalimumab (ADA), etanercept (ETA), and ustekinumab (UST) for psoriasis vulgaris between January 2005 and December 2016 were retrospectively analyzed.

Results

In total, 545 treatment series were administered to 269 patients, including 211 treatment series with ADA, 135 with ETA, 77 with infliximab, and 122 with UST. ADA and ETA were initiated most often as first-line therapy; 65.3% of treatment sequences were discontinued. UST had the highest drug survival. The major reason for treatment termination was a loss of efficacy (44.9%). Definitive discontinuation increased with the number of biologic therapy sequences. Limitations: Subjects were not randomized to the different treatments.

Conclusions

In a long-term real-life setting, drug survival of UST is better than that of TNF-a inhibitors for both biologic-naive and biologic-experienced patients with psoriasis.

Для цитирования: Roche Hélène, Bouiller Kevin, Puzenat Eve, Deveza Elise, Roche Blandine, Pelletier Fabien, van de Laak Alison, Dupond Anne Sophie, Nardin Charlée, Aubin François. Efficacy and survival of biologic agents in psoriasis: a practical real-life 12-year experience in a French dermatology department.. The Journal of dermatological treatment. 2019. DOI: 10.1080/09546634.2018.1480746.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.